(Q48595709)

13 February 2018

title

Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis. (English)

1 reference

13 February 2018

main subject

phase II clinical trial

0 references

1 reference

1 reference

Marc C Chamberlain

1

1 reference

13 February 2018

Denice D Tsao-Wei

series ordinal

2

1 reference

13 February 2018

Susan Groshen

series ordinal

3

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 May 2006

1 reference

13 February 2018

published in

Cancer

1 reference

13 February 2018

volume

106

1 reference

13 February 2018

issue

9

1 reference

13 February 2018

page(s)

2021-2027

1 reference

13 February 2018

Leptomeningeal carcinomatosis. Presenting features and prognostic factors.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

Leptomeningeal metastases: 111indium-DTPA CSF flow studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

Clinical outcome in aggressively treated meningeal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Neoplastic meningitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Adjuvant chemotherapy in the surgical treatment of large bowel cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Central nervous system pharmacokinetics of high-dose cytosine arabinoside.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

High-dose methotrexate: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Intrathecal administration of etoposide in the treatment of malignant meningitis: feasibility and pharmacokinetic data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Feasibility of long-term intraventricular therapy with mafosfamide (n = 26) and etoposide (n = 11): experience in 26 children with disseminated malignant brain tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21828

7 January 2021

Identifiers

DOI

10.1002/CNCR.21828

1 reference

13 February 2018

1 reference

13 February 2018